EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Second-hit CDH1 gene mechanisms in hereditary diffuse gastric and lobular breast cancer syndrome: frequency and impact on tumorigenesis

Giovanni Corso, Francesca Magnoni, Matteo Dal Molin, Elena Marino, Luca Nicosia, Filippo Pesapane, Douglas M Noonan, Adriana Albini

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddaf092 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Giovanni Corso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, European Institute of Oncology, IRCCS, via Ripamonti, 435 - 20141 - Milan, Italy. Hauptthemen laut MEDLINE: Stomach Neoplasms, Breast Neoplasms, Antigens, CD, Cdh1 Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary diffuse gastric and lobular breast cancer (HDGLBC) is an inherited cancer syndrome predominantly characterized by diffuse gastric cancer (DGC) and lobular breast cancer (LBC). LBC often serves as the initial manifestation of HDGLBC, even in the absence of DGC symptoms. Despite advancements in medical technology and treatment, gastric cancer remains a major health burden globally. Approximately 1%–3% of gastric cancers are attributed to hereditary cancer syndromes, with pathogenic variants in the CDH1 gene being a significant contributor. CDH1 encodes E-cadherin, a protein essential for cell–cell adhesion in epithelial tissues. CDH1 inactivation through germline mutations leads to a high risk of developing DGC and LBC. The inactivation process involves a ‘second hit’ mechanism, commonly promoter methylation, leading to the loss of E-cadherin expression and subsequent tumorigenesis. Additionally, mechanisms such as loss of heterozygosity and somatic mutations contribute to CDH1 inactivation. Current research highlights the complexity of these mechanisms and their role in HDGLBC pathogenesis. Therapeutic strategies targeting these pathways, including epigenetic drugs and synthetic lethal approaches, show promise in restoring CDH1 function and inhibiting tumor progression. Given the aggressive nature of HDGLBC, early diagnosis and personalized treatment plans are crucial. Surveillance for LBC in CDH1 mutation carriers should be prioritized, considering prophylactic mastectomy and chemoprevention. This narrative review highlights the need for understanding the genetic and epigenetic alterations in HDGLBC, which provide critical insights for developing effective therapies and improving patient outcomes. Further research is necessary to refine these strategies and explore novel therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsBreast NeoplasmsAntigens, CDCdh1 ProteinsCarcinogenesisCadherinsNeoplastic Syndromes, HereditaryCarcinoma, LobularHumansFemaleGerm-Line MutationGenetic Predisposition to DiseaseDNA Methylation

Stichwörter der Autor:innen

CDH1 genebreast cancergastric cancerlobular breast cancersecond hit mechanism

Substanzen

CDH1 protein, humanAntigens, CDCdh1 ProteinsCadherins

Autor:innen und Institutionen

  • Division of Breast Surgery, European Institute of Oncology, IRCCS, via Ripamonti, 435 - 20141 - Milan, Italy.
  • Department of Oncology and Hematology, University of Milano, via Ripamonti, 435 - 20141 - Milan, Italy.
  • Clinic Unit of Oncogenomics, IEO, IRCCS, via Ripamonti, 435 - 20141 - Milan, Italy.
  • Division of Breast Imaging, European Institute of Oncology, IRCCS, via Ripamonti, 435 - 20141 - Milan, Italy.
  • MultiMedica, IRCCS, Via Milanese, 300, 20099 Sesto San Giovanni - Milan, Italy.
  • Department of Biotechnology and Life Sciences, University of Insubria, Via J.H. Dunant 3 - 21100 - Varese, Italy.

Zitieren

APA

Corso, G., Magnoni, F., Dal Molin, M., Marino, E., Nicosia, L., Pesapane, F., Noonan, D. M., & Albini, A. (2025). Second-hit CDH1 gene mechanisms in hereditary diffuse gastric and lobular breast cancer syndrome: frequency and impact on tumorigenesis. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf092

Vancouver

Corso G, Magnoni F, Dal Molin M, Marino E, Nicosia L, Pesapane F, et al. Second-hit CDH1 gene mechanisms in hereditary diffuse gastric and lobular breast cancer syndrome: frequency and impact on tumorigenesis. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf092

BibTeX
@article{Corso2025,
  author = {Corso, Giovanni and Magnoni, Francesca and Dal Molin, Matteo and Marino, Elena and Nicosia, Luca and Pesapane, Filippo and Noonan, Douglas M and Albini, Adriana},
  title = {Second-hit CDH1 gene mechanisms in hereditary diffuse gastric and lobular breast cancer syndrome: frequency and impact on tumorigenesis},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddaf092}
}
Kostenlos starten →